Zydus Lifesciences Ltd. NSE: ZYDUSLIFE | BSE: 532321

Strong Performer, Getting Expensive

Download real time

1044.75 1.15 (0.11%)

31.42% Gain from 52W Low

577.5K

NSE+BSE Volume

NSE 12 Sep, 2025 3:31 PM (IST)

Zydus Lifesciences Ltd. share price target

Zydus Lifesciences Ltd. has an average share price target of 1045.33. The consensus estimate represents an upside of 0.06% from the last price of 1044.75. View 13 reports from 6 analysts offering long-term price targets for Zydus Lifesciences Ltd..

Reco - This broker has downgraded this stock from it's previous report.
(eg. - Buy->Hold)

Target - Broker has maintained previous recommendation but reduced share price target.

Reco - This broker has upgraded this stock from it's previous report.
(eg. - Sell->Hold)

Target - Broker has maintained previous recommendation but increased share price target.

Load latest Google or static link led you to an intermediate page.

Click on any table column to sort reports by date, stock name, broker, price, target, upside or recommendation.

Summary	Date	Stock	Author	LTP	Target	Price at reco (Change since reco%)	Upside(%)	Type	Report		Discuss
	13 Sep 2025	Zydus Lifesciences	Consensus Share Price Target	1044.75	1006.63	-	-3.65	hold	pdf Detailed Estimates
	13 Aug 2023	Zydus Lifesciences	ICICI Securities Limited Reco Target	1044.75	720.00	650.95 (60.50%)	Target met	Accumulate	pdf post cache		Broker Report US biz on a roll ICICI Securities Limited Zydus’s Q1FY24 performance was boosted by solid traction in the US (up 8.4% QoQ). US benefitted from the ongoing shortages and better sales of gRevlimid while it has started facing competition in gTrokendi XR. India branded biz grew 10% ahead of the market growth of 9%. pdf Copy Link Share on Share on Share on Share on Alert
	12 Aug 2023	Zydus Lifesciences	Prabhudas Lilladhar Target	1044.75	650.00	650.95 (60.50%)	Target met	Accumulate	pdf post cache		Broker Report ZYDUS LIFESCIENCES L Prabhudas Lilladhar pdf Copy Link Share on Share on Share on Share on Alert
	11 Aug 2023	Zydus Lifesciences	Motilal Oswal Target	1044.75	610.00	650.95 (60.50%)	Target met	Neutral	pdf post cache		Broker Report US quarterly revenue at historical high Motilal Oswal pdf Copy Link Share on Share on Share on Share on Alert
	28 Jun 2023	Zydus Lifesciences	Sharekhan Target	1044.75	663.00	582.45 (79.37%)	Target met	Buy	pdf post cache		Broker Report Zydus Life Sharekhan pdf Copy Link Share on Share on Share on Share on Alert
	19 May 2023	Zydus Lifesciences	ICICI Direct Reco Target	1044.75	600.00	494.70 (111.19%)	Target met	Buy	pdf post cache		Broker Report Zydus Life Sciences ICICI Direct pdf Copy Link Share on Share on Share on Share on Alert
	19 May 2023	Zydus Lifesciences	ICICI Securities Limited Reco Target	1044.75	590.00	494.70 (111.19%)	Target met	Buy	pdf post cache		Broker Report US trajectory on a strong footing ICICI Securities Limited Zydus Lifesciences’ (Zydus) Q4FY23 performance was driven by traction in its existing products and exclusive launches such as gRevlimid and gTrokendi XR. Revenue growth and margins of the base business were also quite healthy in our opinion. pdf Copy Link Share on Share on Share on Share on Alert
	18 May 2023	Zydus Lifesciences	Prabhudas Lilladhar Target	1044.75	520.00	508.05 (105.64%)	Target met	Accumulate	pdf post cache		Broker Report ZYDUS LIFESCIENCES L Prabhudas Lilladhar pdf Copy Link Share on Share on Share on Share on Alert
	18 May 2023	Zydus Lifesciences	Motilal Oswal Target	1044.75	550.00	508.05 (105.64%)	Target met	Neutral	pdf post cache		Broker Report LimeRoad integration continues to hurt profitability Motilal Oswal pdf Copy Link Share on Share on Share on Share on Alert
	29 Apr 2023	Zydus Lifesciences	BP Wealth	1044.75	597.00	519.90 (100.95%)	Target met	Buy	pdf post cache		Broker Report Zydus Lifesciences Ltd. target price 597 BP Wealth pdf Copy Link Share on Share on Share on Share on Alert
	22 Mar 2023	Zydus Lifesciences	Sharekhan Target	1044.75	572.00	478.65 (118.27%)	Target met	Buy	pdf post cache		Broker Report Zydus Life Sharekhan pdf Copy Link Share on Share on Share on Share on Alert
more loading

* Please note that subscribers can download a maximum of 300 reports a month and 70 reports everyday.

Advisor Screeners